Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences Return on Tangible Equity 2010-2024 | USNA

Current and historical return on tangible equity values for USANA Health Sciences (USNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
USANA Health Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.06B $0.49B 11.84%
2024-06-30 $0.06B $0.47B 12.26%
2024-03-31 $0.06B $0.45B 14.17%
2023-12-31 $0.06B $0.45B 14.81%
2023-09-30 $0.06B $0.42B 14.42%
2023-06-30 $0.06B $0.42B 16.00%
2023-03-31 $0.07B $0.41B 17.28%
2022-12-31 $0.07B $0.39B 19.15%
2022-09-30 $0.08B $0.36B 21.67%
2022-06-30 $0.09B $0.35B 25.29%
2022-03-31 $0.11B $0.34B 30.33%
2021-12-31 $0.12B $0.35B 32.58%
2021-09-30 $0.14B $0.35B 37.01%
2021-06-30 $0.14B $0.37B 38.33%
2021-03-31 $0.13B $0.36B 37.30%
2020-12-31 $0.13B $0.39B 38.44%
2020-09-30 $0.12B $0.34B 38.27%
2020-06-30 $0.11B $0.30B 38.29%
2020-03-31 $0.10B $0.27B 34.89%
2019-12-31 $0.10B $0.31B 31.97%
2019-09-30 $0.10B $0.27B 31.34%
2019-06-30 $0.11B $0.34B 30.68%
2019-03-31 $0.12B $0.34B 33.38%
2018-12-31 $0.13B $0.34B 34.64%
2018-09-30 $0.09B $0.39B 24.74%
2018-06-30 $0.08B $0.38B 24.05%
2018-03-31 $0.07B $0.35B 21.52%
2017-12-31 $0.06B $0.31B 19.73%
2017-09-30 $0.09B $0.31B 29.51%
2017-06-30 $0.10B $0.33B 33.02%
2017-03-31 $0.10B $0.30B 37.68%
2016-12-31 $0.10B $0.27B 42.69%
2016-09-30 $0.10B $0.25B 45.95%
2016-06-30 $0.10B $0.22B 44.04%
2016-03-31 $0.10B $0.19B 43.30%
2015-12-31 $0.10B $0.23B 42.18%
2015-09-30 $0.09B $0.26B 43.45%
2015-06-30 $0.09B $0.23B 46.51%
2015-03-31 $0.08B $0.19B 45.14%
2014-12-31 $0.08B $0.17B 41.82%
2014-09-30 $0.08B $0.14B 39.68%
2014-06-30 $0.07B $0.20B 36.78%
2014-03-31 $0.08B $0.22B 41.43%
2013-12-31 $0.08B $0.20B 47.88%
2013-09-30 $0.08B $0.18B 52.56%
2013-06-30 $0.08B $0.15B 56.51%
2013-03-31 $0.07B $0.13B 54.37%
2012-12-31 $0.07B $0.13B 50.97%
2012-09-30 $0.06B $0.14B 48.22%
2012-06-30 $0.06B $0.12B 47.86%
2012-03-31 $0.05B $0.13B 48.51%
2011-12-31 $0.05B $0.11B 50.00%
2011-09-30 $0.05B $0.10B 52.41%
2011-06-30 $0.05B $0.09B 57.64%
2011-03-31 $0.05B $0.09B 54.18%
2010-12-31 $0.05B $0.09B 55.09%
2010-09-30 $0.04B $0.07B 55.87%
2010-06-30 $0.04B $0.09B 52.00%
2010-03-31 $0.04B $0.08B 58.27%
2009-12-31 $0.03B $0.07B 65.38%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.595B $0.921B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.557B 30.23
Chugai Pharmaceutical (CHGCY) Japan $73.258B 28.91
Takeda Pharmaceutical (TAK) Japan $43.305B 9.58
Sandoz Group AG (SDZNY) Switzerland $21.476B 0.00
Merck (MKKGY) Germany $19.083B 17.09
Astellas Pharma (ALPMY) Japan $16.957B 12.01
United Therapeutics (UTHR) United States $15.793B 15.54
Summit Therapeutics (SMMT) United States $15.243B 0.00
Neurocrine Biosciences (NBIX) United States $15.239B 45.75
Shionogi (SGIOY) Japan $12.318B 12.34
Orion OYJ (ORINY) Finland $7.466B 20.99
Madrigal Pharmaceuticals (MDGL) United States $7.203B 0.00
Corcept Therapeutics (CORT) United States $7.129B 54.00
Stevanato Group S.p.A (STVN) Italy $6.808B 44.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.152B 0.00
Grifols, S.A (GRFS) Spain $4.806B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.779B 9.78
Crinetics Pharmaceuticals (CRNX) United States $3.590B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.750B 12.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
Centessa Pharmaceuticals (CNTA) United Kingdom $2.352B 0.00
Soleno Therapeutics (SLNO) United States $2.198B 0.00
Hypermarcas (HYPMY) Brazil $2.068B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.949B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.808B 0.00
Dyne Therapeutics (DYN) United States $1.706B 0.00
Evotec AG (EVO) Germany $1.666B 0.00
Indivior (INDV) United States $1.468B 5.98
Guardian Pharmacy Services (GRDN) United States $1.408B 0.00
Ardelyx (ARDX) United States $1.343B 0.00
ARS Pharmaceuticals (SPRY) United States $1.244B 0.00
Xencor (XNCR) United States $1.207B 0.00
Ocular Therapeutix (OCUL) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.158B 0.00
Harrow (HROW) United States $1.105B 0.00
Enliven Therapeutics (ELVN) United States $1.098B 0.00
Collegium Pharmaceutical (COLL) United States $0.998B 5.45
Bioventus (BVS) United States $0.880B 27.80
Cronos Group (CRON) Canada $0.773B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.771B 0.00
Relay Therapeutics (RLAY) United States $0.755B 0.00
Verve Therapeutics (VERV) United States $0.708B 0.00
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Xeris Biopharma Holdings (XERS) United States $0.540B 0.00
OmniAb (OABI) United States $0.524B 0.00
Altimmune (ALT) United States $0.491B 0.00
Savara (SVRA) United States $0.487B 0.00
ProKidney (PROK) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Akebia Therapeutics (AKBA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Oruka Therapeutics (ORKA) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.446B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 174.21
Zevra Therapeutics (ZVRA) United States $0.421B 0.00
Siga Technologies (SIGA) United States $0.413B 4.82
Tourmaline Bio (TRML) United States $0.384B 0.00
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Aldeyra Therapeutics (ALDX) United States $0.357B 0.00
Korro Bio (KRRO) United States $0.339B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
4D Molecular Therapeutics (FDMT) United States $0.301B 0.00
CytoDyn (CYDY) United States $0.277B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.272B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 16.10
Amylyx Pharmaceuticals (AMLX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Lexeo Therapeutics (LXEO) United States $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Lyell Immunopharma (LYEL) United States $0.173B 0.00
Silence Therapeutics (SLN) United Kingdom $0.172B 0.00
Inhibikase Therapeutics (IKT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Nanobiotix S.A (NBTX) France $0.166B 0.00
Champions Oncology (CSBR) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Telomir Pharmaceuticals (TELO) United States $0.135B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
ElectroCore (ECOR) United States $0.106B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Protara Therapeutics (TARA) United States $0.100B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.20
ESSA Pharma (EPIX) Canada $0.075B 0.00
Mural Oncology (MURA) Ireland $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Century Therapeutics (IPSC) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Incannex Healthcare (IXHL) Australia $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Traws Pharma (TRAW) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Dominari Holdings (DOMH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
SHINECO (SISI) China $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00